Ropidoxuridine
S22-11168
Phase 2 small_molecule terminated
Quick answer
Ropidoxuridine for Glioblastoma, IDH-wildtype is a Phase 2 program (small_molecule) at Shuttle Pharmaceuticals Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shuttle Pharmaceuticals Holdings
- Indication
- Glioblastoma, IDH-wildtype
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated